Skip to main content
OpenTrials

Clinical trial condition

COVID-19

Explore clinical trials studying COVID-19. Study availability and eligibility vary by location and protocol.

1,904 public trials 96 recruiting studies
Refine in advanced search Browse all conditions

COVID-19 trial results

Completed

Safety and Immunogenicity of NVX-CoV2705

NCT07079670

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Investigational Site Number US404 Phoenix, Arizona, United States
  • Investigational Site Number US395 Melrose Park, Illinois, United States
  • Investigational Site Number US406 Lenexa, Kansas, United States
  • Investigational Site Number US294 Lafayette, Louisiana, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

NCT06291857

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations
  • Paratus Clinical Research - Canberra - PPDS Bruce, Australian Capital Territory, Australia
  • Momentum Wellers Wellers Hill, Brisbane, Australia
  • Paratus Clinical Research - Western Sydney - PPDS Blacktown, New South Wales, Australia
  • Key Health- Bondi Junction Bondi Junction, New South Wales, Australia
View all 58 locations
View Trial Details
Completed

A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

NCT07069309

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Diablo Clinical Research, Inc. Walnut Creek, California, United States
  • Clinical Research Consulting Milford, Connecticut, United States
  • GW Vaccine Research Unit Washington D.C., District of Columbia, United States
  • The GW Medical Faculty Associates Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

NCT05468736

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • Preferred Research Partners, Inc. Little Rock, Arkansas, United States
  • Advanced Research Center Anaheim, California, United States
  • Coast Clinical Research, LLC Bellflower, California, United States
  • Apex Research Group Fair Oaks, California, United States
View all 94 locations
View Trial Details

Related conditions